表紙
市場調査レポート

医療機器分野における非公開投資会社とベンチャーキャピタル(PE/VC)の活動―過去4年間における小規模企業向け投資の増加

Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years

発行 GBI Research 商品コード 227395
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
医療機器分野における非公開投資会社とベンチャーキャピタル(PE/VC)の活動―過去4年間における小規模企業向け投資の増加 Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
出版日: 2011年07月01日 ページ情報: 英文 90 Pages
概要

当レポートは、体外診断薬をはじめとする18種の医療機器市場における非公開投資会社とベンチャーキャピタル(PE/VC)の投資活動について調査分析するとともに、投資に影響を及ぼし得る要因などについてまとめ、概略下記の内容でお届けするものです。

目次

第1章 目次

第2章 イントロダクション

  • GBI報告書に関するガイダンス

第3章 PE/VCによる医療機器分野への投資

  • 件数および金額でみたPE/VCの投資(2007-10年)
  • 進行状況で分類したPE/VCの投資(2007-10年)
  • 中止された案件

第4章 地域別にみたPE/VCによる投資

  • 北米
  • 欧州
  • アジア太平洋

第5章 医療機器市場別にみたPE/VCによる投資

第6章 世界の医療機器市場と主な財務顧問

第7章 付録

目次

Scope

  • Key geographies covered include North America, Europe and the Asia-Pacific.
  • PE/VC activity in the following market categories - In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, ENT Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management
  • PE/VC deals from 2007 to 2010 in the medical device market and detailed analysis of deals greater than $100m in size.
  • The report also covers top financial advisors for the PE/VC deals from 2007 to 2010 in the medical device market.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the medical devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit PE/VC opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • What's the next big thing in the PE/VC activity in medical devices landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global medical devices market and the factors shaping it.

Executive Summary

GBI Research's report, “Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years” provides key data, information and analysis on the global medical devices market. The report provides private equity and venture capital (PE/VC) activity in 18 medical device market categories - In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, Ear, Nose and Throat Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management. The report provides comprehensive information on the factors affecting PE/VC investment in these categories. The report also reviews the detailed analysis of the PE/VC deals worth greater than $100m in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

In Vitro Diagnostics (IVD), Cardiovascular Devices and Healthcare IT Markets Attracted the Most PE/VC Investments in 2010

A total of 769 private equity (PE) and venture capital (VC) financing deals took place in 2010, compared to 556 in 2009. In 2010, the in vitro diagnostics (IVD), cardiovascular devices and healthcare IT markets attracted the most PE/VC investments, with shares of 20%, 13% and 10% respectively. Within the IVD devices categories, it is the immunochemistry and clinical chemistry categories that are gaining investor attention. In the cardiovascular devices market, it is interventional cardiology that has proved attractive. In interventional cardiology, minimally invasive techniques are being widely chosen by the patient population, thus resulting in the uptake of catheter approaches for congestive heart failure, mitral valve repair and the next generation stents. Large companies are showing an interest and investing in the research and development (R&D) of minimally invasive techniques to treat coronary artery disease and valve repair. The other major categories that received PE/VC investor attention were orthopedic devices, surgical equipment and diagnostic imaging.

In addition, there is a growing awareness regarding the use of information technology (IT) in healthcare to maintain efficient and productive use of the available resources. There is a growing investment in the healthcare IT and IVD markets due to increasing advancements and awareness of the use of IT services to maintain an efficient and effective healthcare system. The increase in the diseased population has led to development of diagnostic devices more capable of detecting diseases with ease and accuracy. Moreover, PE/VC firms look for startup companies with promising technologies to invest in.

PE/VC Investment in Start-up Firms was the Predominant Strategy that Investors Followed in 2010

In 2010, the various stages of medical devices companies in which PE/VC funding was aimed at start-up medical device firms with 53% of the total 769 deals. The second most adopted strategy for investment was in the expansion stage, with 21%, followed by later stage investments, with 16%. PE/VC funding was adopted by investors and medical device companies to give high speed access to new advanced technologies and avoid barriers to entry, expand their portfolio of products and to improve their asset valuations. From 2007-2010, PE/VCs increased their financial investments in the medical device market because of the apparent high potential of the North American and European healthcare sectors. VC firms invest in early-stage companies with high potential for future growth. Similarly, PE firms invest in start-ups, and help them to streamline their operations. Start-up companies in medical devices are started by innovators who have little knowledge or experience of entrepreneurship. PE/VCs help these companies by providing adequate management support. However, these firms invest with an intention of profitable exits from their investments. The biggest exit strategies for PE/VCs are public offerings or acquisitions by other bigger companies. Startup firms are more focused on developing new technologies and work on ways of commercializing technology. Therefore, PE/VC investment is being increasingly seen in start-up firms.

The Majority of PE/VC Financing in Medical Devices that Took Place from 2007 to 2010 were of Deal Value Less than $10m

The majority of PE/VC funding for the medical devices industry from 2007 to 2010 was for deal values of less than $10m. The medical equipment market offers strong growth prospects and is highly regulated and driven by constant technological innovation. The two largest markets for medical equipment are the US and European Union (EU). The recent trends for financing have undergone a significant change due to the changing scenario worldwide. Out of the various options available, investors are financing more in start-up firms. The medical device industry is highly fragmented and the need for new technological innovation is huge. There are many small players with annual revenues of less than $5m. Small innovative firms are associated with developing new medical technology products. Most of these organizations specialize in only one technology and much redundancy exists between companies. Start-up firms in medical device companies are groomed by investors so that they can be acquired by larger companies. Small firms, after receiving US FDA marketing approval for their products, are targeted for acquisition by large medical equipment companies. There exists an advantage for both small and large firms. Small firms benefit from added resources, while large firms gain from advanced technologies. Therefore all these factors and the fiscal pressure of staying afloat are compelling many smaller firms to merge with larger ones.

North America is the Biggest Market for PE/VC Deals in Medical Devices Industry in 2010

North America is one of the biggest markets for PE/VC investment in medical devices. Between 2007 and 2010, the targets for medical device PE/VC deals were concentrated heavily in the US, Canada, Europe and the Asia-Pacific. The US is the most attractive venue for PE/VC deals in the global medical devices industry due to a higher concentration of companies with key products and technologies in the development stage. A robust research program, considerable public and private funding opportunities, the protection of intellectual property, ample infrastructure and public entrepreneurship programs have created the perfect mix for medical technology innovation in the US.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GBI Research Report Guidance

3. PE/VC Deals Summary in the Medical Device Industry

  • 3.1. PE/VC Deals by Number and Deal Value, 2007-2010
  • 3.2. Segmentation of PE/VC Deals by Stages, 2007-2010
    • 3.2.1. Conclusion
  • 3.3. Withdrawn/Terminated Deals
    • 3.3.1. Ion Beam Applications Terminated Sale of Its BioAssays Unit
    • 3.3.2. Smiths Group Rejects Cash Bid of Apax Partners for Smiths Medical
    • 3.3.3. Ares Life Sciences, Essex, Intesa and Alpha Terminated Acquisition of Sorin
    • 3.3.4. AMICAS Terminated Acquisition with Thoma Bravo
    • 3.3.5. Q-Med Terminated Offer for Its Acquisition by Ivytan
    • 3.3.6. Endologix Terminated Offer for Its Acquisition by Elliot Associates
    • 3.3.7. Conclusion

4. PE/VC Deals in Medical Devices by Geography

  • 4.1. PE/VC Deals in North America
  • 4.2. PE/VC Deals in Europe
  • 4.3. PE/VC Deals in the Asia-Pacific
    • 4.3.1. Conclusion

5. PE/VC Activity in Medical Devices by Market

  • 5.1. In Vitro Diagnostics
    • 5.1.1. Deals Analysis
    • 5.1.2. PE/VC Deals - In Vitro Diagnostics
    • 5.1.3. Pacific Biosciences Secured Additional $59m in Series F Round of Financing
    • 5.1.4. Legal & General Ventures Sells LGC to Bridgepoint
    • 5.1.5. Welsh, Carson, Anderson & Stowe Acquired Spectrum Laboratory Network from Apax Partners
    • 5.1.6. Bridgepoint Capital Acquired Terveystalo Healthcare
    • 5.1.7. Duke Street Acquired Biomnis
    • 5.1.8. The EQT V fund Acquired Dako Denmark
  • 5.2. Cardiovascular Devices
    • 5.2.1. Deal Analysis
    • 5.2.2. Ares Life Sciences Acquired Stake in Esaote
    • 5.2.3. Boston Scientific Sells Fluid Management and Venous Access Businesses To Avista Capital
    • 5.2.4. Cardionet Secures $110m in Series E Financing
  • 5.3. Orthopedic Devices
    • 5.3.1. Deals Analysis
    • 5.3.2. Small Bone Innovations Secured $108m in Series D Financing
    • 5.3.3. Globus Medical Secures $110m Series E Financing
  • 5.4. Anesthesia and Respiratory Devices
    • 5.4.1. Deals Analysis
    • 5.4.2. Water Street Healthcare Acquires Stake in CareCentrix from Gentiva Health
  • 5.5. Dental Devices
    • 5.5.1. Deals Analysis
    • 5.5.2. TA Associates Acquired Stake in Amann Girrbach
    • 5.5.3. Palamon Capital Partners Completes Acquisition of Associated Dental Partners
  • 5.6. Diabetes Care Devices
    • 5.6.1. Deals Analysis
    • 5.6.2. The Blackstone Group Acquires Apria Healthcare
  • 5.7. Diagnostic Imaging
    • 5.7.1. Deals Analysis
    • 5.7.2. Bridgepoint Capital Acquired Terveystalo Healthcare
    • 5.7.3. Merrill Lynch and Ares Acquires Euromedic from Warburg Pincus
    • 5.7.4. Avista Capital Partners Acquired Bristol-Myers Squibb Medical Imaging
    • 5.7.5. Dubai International Capital Acquired Alliance Medical from Bridgepoint Capital
    • 5.7.6. DeA Capital and Mediobanca Acquired 53% Majority Stake in Generale de Sante
  • 5.8. Drug Delivery Devices
    • 5.8.1. Deals Analysis
    • 5.8.2. Warburg Pincus Acquired Lifecore Biomedical
  • 5.9. Endoscopy Devices
    • 5.9.1. Deals Analysis
    • 5.9.2. TPG Capital Acquires Axcan Pharma
  • 5.10. Ear, Nose and Throat (ENT) Devices
    • 5.10.1. Deals Analysis
    • 5.10.2. Technitrol Sells Medtech Component Business To Altor
  • 5.11. Healthcare IT
    • 5.11.1. Huntsman Gay Global Acquires 51% Stake in Sunquest Information from Vista Equity Partners
    • 5.11.2. BC Partners and Silver Lake Acquires MultiPlan from the Carlyle Group and Welsh, Carson, Anderson & Stowe
    • 5.11.3. OMERS Private Equity Completes Acquisition of Logibec Groupe Informatique
    • 5.11.4. Francisco Partners Completes Acquisition Of Quadramed
    • 5.11.5. ikaSystems Received Additional Investment From Essex Woodlands Health
    • 5.11.6. Truveris Raises $3.8m in First Venture Financing Round
    • 5.11.7. Glocal Healthcare Systems to Raise $3.25m in Venture Financing
    • 5.11.8. Apax Partners, Bluecross Blueshield and Regence Group Acquired the TriZetto Group
    • 5.11.9. Merrill Lynch and Ares Acquired Euromedic From Warburg Pincus
    • 5.11.10. General Atlantic And Hellman & Friedman Acquires Remaining 48% Stake In Emdeon Business Services From HLTH
    • 5.11.11. TA Associates Acquired Alere Medical
  • 5.12. Hospital Supplies
    • 5.12.1. Deals Analysis
    • 5.12.2. The Blackstone Group Completes Acquisition of Polymer Group
    • 5.12.3. EQT Partners Completed Acquisition of HTL-Strefa
    • 5.12.4. Lehman Brothers Acquired Angelica
    • 5.12.5. Tenet Healthcare Sells Its Majority Stake in Broadlane to TowerBrook Capital Partners
  • 5.13. Nephrology and Urology Devices
    • 5.13.1. Deals Analysis
    • 5.13.2. Merrill Lynch and Ares Acquired Euromedic from Warburg Pincus
  • 5.14. Neurology Devices
    • 5.14.1. Deals Analysis
  • 5.15. Ophthalmic Devices
    • 5.15.1. 3i Acquired Ultralase from Corporacion Dermoestetica
    • 5.15.2. Warburg Pincus Acquired Bausch & Lomb
  • 5.16. Patient Monitoring
    • 5.16.1. Deals Analysis
    • 5.16.2. TA Associates Acquired Alere Medical
  • 5.17. Surgical Equipment
    • 5.17.1. Deals Analysis
    • 5.17.2. PerkinElmer Sells Illumination and Detection Solutions Business to Veritas Capital Fund Management
    • 5.17.3. HLTH Sells Porex to Aurora Capital
  • 5.18. Wound Care Management
    • 5.18.2. Investor Acquired 34% Stake in Molnlycke Health Care
    • 5.18.3. Nordic Capital Fund and Avista Capital Partners Acquire ConvaTec from Bristol-Myers Squibb
    • 5.18.4. Investor and Morgan Stanley Completed Acquisition of Molnlycke Health Care from Apax Partners

6. Global Medical Devices, Top Financial Advisors

  • 6.1. Top Financial Advisors, PE/VC Deals Medical Devices

7. PE/VC Activity in Medical Devices- Appendix

  • 7.1. Acronyms
  • 7.2. Research Methodology
    • 7.2.1. Secondary Research
    • 7.2.2. Primary Research
    • 7.2.3. Models
    • 7.2.4. Forecasts
    • 7.2.5. Expert Panels
  • 7.3. Contact Us
  • 7.4. Disclaimer
  • 7.5. Sources

List of Tables

  • Table 1: Medical Devices Market, Global, PE/VC, by Number of Deals and Deal Value, 2007-2010
  • Table 2: Medical Devices Industry, Global, PE/VC Deals, Number of Deals by Stages, 2007-2010
  • Table 3: Medical Devices Industry, Global, PE/VC Deals, Withdrawn/Terminated Deals, 2007-2010
  • Table 4: Medical Devices Industry, North America, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010
  • Table 5: Medical Devices, Europe, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010
  • Table 6: Medical Devices Industry, Asia-Pacific, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010
  • Table 7: In Vitro Diagnostics Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 8: In Vitro Diagnostics Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 9: In Vitro Diagnostics, Global, PE/VC Deals, 2007-2010
  • Table 10: Cardiovascular Devices Market, Global, PE/VCs, by Number of Deals, 2007-2010
  • Table 11: Cardiovascular Devices Market, Global, PE/VCs, by Deal Value ($m), 2007-2010
  • Table 12: Cardiovascular Devices, Global, PE/VC, 2007-2010
  • Table 13: Orthopedic Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 14: Orthopedic Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 15: Orthopedics Devices Market, Global, PE/VC, 2007-2010
  • Table 16: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 17: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 18: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Volume, 2007-2010
  • Table 19: Dental Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 20: Dental Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 21: Dental Devices Market, Global, PE/VC, 2007-2010
  • Table 22: Diabetes Care Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 23: Diabetes Care Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 24: Diabetes Care Devices, Global, PE/VC, 2007-2010
  • Table 25: Diagnostic Imaging Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 26: Diagnostic Imaging Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 27: Diagnostic Imaging Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 28: Drug Delivery Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 29: Drug Delivery Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 30: Drug Delivery Devices, Global, PE/VC, 2007-2010
  • Table 31: Endoscopy Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 32: Endoscopy Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 33: Endoscopy Devices Market, PE/VC, by Volume, Global, 2007-2010
  • Table 34: ENT Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 35: ENT Devices Market, PE/VC, by Deal Value ($m), Global, 2007-2010
  • Table 36: ENT Devices Market, Global, PE/VC, by Deal Volume, 2007-2010
  • Table 37: Healthcare IT Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 38: Healthcare IT Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 39: Healthcare IT Market, Global, PE/VC, by Deal Volume, 2007-2010
  • Table 40: Hospital Supplies Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 41: Hospital Supplies Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 42: Hospital Supplies Market, Global, PE/VC, by Deal Volume, 2007-2010
  • Table 43: Nephrology and Urology Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 44: Nephrology and Urology Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 45: Nephrology and Urology Devices Market, Global, PE/VC, by Deal Volume, 2007-2010
  • Table 46: Neurology Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 47: Neurology Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 48: Ophthalmic Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 49: Ophthalmic Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 50: Ophthalmic Devices Market, Global, PE/VC, by Deal Volume 2007-2010
  • Table 51: Patient Monitoring Devices Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 52: Patient Monitoring Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 53: Patient Monitoring Devices Market, Global, PE/VC, by Deal Volume, 2007-2010
  • Table 54: Surgical Equipment Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 55: Surgical Equipment Market, Global, PE/VC, Deal Value ($m), 2007-2010
  • Table 56: Surgical Equipment Market, Global, PE/VC, 2007-2010
  • Table 57: Wound Care Management Market, Global, PE/VC, by Number of Deals, 2007-2010
  • Table 58: Wound Care Management Market, Global, PE/VC, by Deal Value ($m), 2007-2010
  • Table 59: Wound Care Management, Global, PE/VC Deals, 2007-2010
  • Table 60: Medical Devices, Top Legal Advisors, 2007-2010

List of Figures

  • Figure 1: Medical Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 2: Medical Devices Industry, Global, PE/VC Deals, Deals by Stages (%), 2007-2010
  • Figure 3: Medical Devices Industry, North America, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010
  • Figure 4: Medical Devices Industry, Europe, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010
  • Figure 5: Medical Devices Industry, Asia-Pacific, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010
  • Figure 6: In Vitro Diagnostics Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 7: Cardiovascular Devices Market, Global, PE/VCs, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 8: Orthopedic Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 9: Orthopedic Devices, Global, Pipeline Products Summary, 2010
  • Figure 10: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 11: Dental Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 12: Diabetes Care Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 13: Diagnostic Imaging Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 14: Drug Delivery Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 15: Endoscopy Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 16: ENT Devices Market, PE/VC, Global, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 17: Healthcare IT Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 18: Hospital Supplies Market, PE/VC, Global, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 19: Nephrology and Urology Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 20: Neurology Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 21: Ophthalmic Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 22: Patient Monitoring Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 23: Surgical Equipment Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 24: Wound Care Management Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010
  • Figure 25: Medical Devices, Global, PE/VC Deals, Top Financial Advisors, 2007-2010
Back to Top